Browse Technologies by  


UPN Ref Technology
149 AN INNOVATIVE DISPOSABLE AIR-BUBBLE TRAP FOR IV-INFUSIONS FOR MEDICAL PROCEDURES
An innovative air-bubble, cheap, disposable trap used for IV medical infusions using nano-technology.
View Technology
143 Innovative encapsulation technologies for controlled release of functional ingredients and medicinals
A serie of core technologies that are based on patented encapsulation techniques designed for targeted and controlled release of vaccines, antibiotics, probiotics, nutrients and a wide range of sensitive food ingredients. Efficiency systems have proven to be efficient “DHL” ingredient delivery services in the human and animal body. In this way, this can help industry to enhance and develop new products with proven health claims.
View Technology
70 A safe, non-toxic, edible, organic nano-material for use in multiple applications
A safe, non-toxic, edible, organic, low-cost, nanomaterial that can be applied in many applications including: Personal Care, Cosmetics, Pharmaceutical, Nutraceutical, Agri-chemical and Food Products. The company's mission is to fulfill a rapidly growing global demand for eco-friendly polymers produced from sustainable sources that also enhance the performance of consumer products and provide new and unique properties.
View Technology
59 Unique nanofiber production method
A technology that enables nanofibers to be produced at a much higher rate than conventional electrospinning. The process enables new applications for nanofibers.
View Technology
47 In-vitro model to simulate digestion
In-vitro static digestion model to evaluate the bioavailability, bioaccessibility and beneficial effects of proteins, single compounds, complex formulations and nanoparticles.
View Technology
45 Aptamer-Based Therapeutics
The Innovator’s technology blocks the 3’ end of aptamers and other DNA oligonucleotides (e.g., antisense DNA) with proteins to stabilize these potentially therapeutic molecules in the body. The proteins can be simple serum albumins or more functional proteins such as the Fc tails of IgG antibodies or C1q to trigger the immune (complement) system to opsonize (phagocytize) or punch holes in cancer cells, Gram negative antibiotic-resistant bacteria and parasites. Specific aptamer sequences can also be used to coat deadly viruses such as West Nile and dengue viruses to curb their progression in vivo.
View Technology
40 A bacteriophage lysates production technology
A method for the commercial production of bacteriophages composition. The method decreases the production volume and increases the production yields.
View Technology
38 Nanopore technology platform
A nanopore technology platform that enables high-throughput measurements of particles as they passes through a pore. The highly precise analytical nanotechnology uses tunable nanopore-based measurement to rapidly determine the size, charge and concentration of particle populations with individual particle resolution.
View Technology
36 Surgical tissue sealant
A light-activated, biocompatible and fully biodegradable surgical tissue sealant. Based on EITHER fibrinogen OR gelatin, the sealant presents high burst strength, is low-swelling, biocompatible, and has been developed for soft tissues applications.
View Technology
35 Advanced in-vitro model to evaluate the disposition and bio-performance of oral pharmaceuticals and nutritional products.
A dynamic in-vitro system that fully replicates the complex biochemical conditions and the array of gastric forces crucial for the prediction of the bio-performance of pharmaceuticals and nutritional based materials.
View Technology
slider